Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud Delwel

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Blood|February 10, 2017
Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformationRoberto Avellino, Ruud Delwel
FEBS Letters|July 16, 2008
A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9aDominik Spensberger, Ruud Delwel
Hemasphere|November 13, 2023
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in HematopoiesisRoger Mulet-Lazaro, Ruud Delwel
Blood Cancer Discovery|August 2, 2024
Oncogenic Enhancers in LeukemiaRoger Mulet-Lazaro, Ruud Delwel
Blood|December 15, 2015
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaBas J Wouters, Ruud Delwel
Blood Cancer Discovery|April 16, 2025
One for All and All for One: New Insights into Enhancers Driving MYC DysregulationRoger Mulet-Lazaro, Ruud Delwel
International Journal of Cancer|January 24, 2025
Mechanisms of enhancer-driven oncogene activationJoyce Vriend, Ruud Delwel, Dorien Pastoors
Methods in Molecular Biology (Clifton, N.J.)|August 27, 2013
HAT: a novel statistical approach to discover functional regions in the genomeErdogan Taskesen, Bas Wouters, Ruud Delwel
Blood|August 16, 2008
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBas J Wouters, Bob Löwenberg, Ruud Delwel
Blood|October 31, 2002
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiationMeritxell Alberich Jordà, Bob Lowenberg, Ruud Delwel
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Blood|February 10, 2017
Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformationRoberto Avellino, Ruud Delwel
FEBS Letters|July 16, 2008
A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9aDominik Spensberger, Ruud Delwel
Hemasphere|November 13, 2023
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in HematopoiesisRoger Mulet-Lazaro, Ruud Delwel
Blood Cancer Discovery|August 2, 2024
Oncogenic Enhancers in LeukemiaRoger Mulet-Lazaro, Ruud Delwel
Blood|December 15, 2015
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaBas J Wouters, Ruud Delwel
Blood Cancer Discovery|April 16, 2025
One for All and All for One: New Insights into Enhancers Driving MYC DysregulationRoger Mulet-Lazaro, Ruud Delwel
International Journal of Cancer|January 24, 2025
Mechanisms of enhancer-driven oncogene activationJoyce Vriend, Ruud Delwel, Dorien Pastoors
Methods in Molecular Biology (Clifton, N.J.)|August 27, 2013
HAT: a novel statistical approach to discover functional regions in the genomeErdogan Taskesen, Bas Wouters, Ruud Delwel
Blood|August 16, 2008
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBas J Wouters, Bob Löwenberg, Ruud Delwel
Blood|October 31, 2002
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiationMeritxell Alberich Jordà, Bob Lowenberg, Ruud Delwel
Pageof 14